HDL as a biomarker, potential therapeutic target, and therapy

Diabetes. 2009 Dec;58(12):2711-7. doi: 10.2337/db09-0538.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute-Phase Reaction / metabolism*
  • Animals
  • Animals, Inbred Strains
  • Apolipoprotein A-I / metabolism
  • Biomarkers
  • Cholesterol, HDL / blood
  • Cholesterol, HDL / metabolism*
  • Cholesterol, LDL / metabolism
  • Coronary Disease / metabolism
  • Diabetes Mellitus / metabolism*
  • Hemoglobins / metabolism
  • Humans
  • Hyperlipoproteinemia Type II / metabolism
  • Leprosy / metabolism
  • Lipid Peroxidation
  • Lupus Erythematosus, Systemic / metabolism
  • Metabolic Syndrome / metabolism
  • Mice
  • Obesity / metabolism
  • Oxidative Stress
  • Predictive Value of Tests
  • Rabbits
  • Risk Assessment
  • Risk Factors

Substances

  • Apolipoprotein A-I
  • Biomarkers
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hemoglobins